Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Immune responses to human papillomavirus in genital tract of women with cervical cancer.

Nguyen HH, Broker TR, Chow LT, Alvarez RD, Vu HL, Andrasi J, Brewer LR, Jin G, Mestecky J.

Gynecol Oncol. 2005 Feb;96(2):452-61.

PMID:
15661235
[PubMed - indexed for MEDLINE]
2.

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

Bontkes HJ, de Gruijl TD, Walboomers JM, Schiller JT, Dillner J, Helmerhorst TJ, Verheijen RH, Scheper RJ, Meijer CJ.

J Gen Virol. 1999 Feb;80 ( Pt 2):409-17.

PMID:
10073701
[PubMed - indexed for MEDLINE]
Free Article
3.

Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.

Sasagawa T, Inoue M, Lehtinen M, Zhang W, Gschmeissner SE, Hajibagheri MA, Finch J, Crawford L.

Clin Diagn Lab Immunol. 1996 Jul;3(4):403-10.

PMID:
8807204
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.

de Gruijl TD, Bontkes HJ, Walboomers JM, Stukart MJ, Robbesom AA, von Blomberg-van der Flier BM, Herbrink P, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ.

Int J Cancer. 1996 Dec 11;68(6):731-8.

PMID:
8980175
[PubMed - indexed for MEDLINE]
5.

Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals.

Luxton JC, Rowe AJ, Cridland JC, Coletart T, Wilson P, Shepherd PS.

J Gen Virol. 1996 Jul;77 ( Pt 7):1585-93.

PMID:
8758003
[PubMed - indexed for MEDLINE]
Free Article
6.

Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids.

Sasagawa T, Rose RC, Azar KK, Sakai A, Inoue M.

Int J Cancer. 2003 Apr 10;104(3):328-35.

PMID:
12569556
[PubMed - indexed for MEDLINE]
7.

Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study.

Sarkar AK, Tortolero-Luna G, Follen M, Sastry KJ.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S251-61. Epub 2005 Sep 26.

PMID:
16188303
[PubMed - indexed for MEDLINE]
8.

Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.

Passmore JA, Burch VC, Shephard EG, Marais DJ, Allan B, Kay P, Rose RC, Williamson AL.

J Med Virol. 2002 Jun;67(2):234-40.

PMID:
11992584
[PubMed - indexed for MEDLINE]
9.

Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.

Passmore JA, Milner M, Denny L, Sampson C, Marais DJ, Allan B, Gumbi PP, Hitzeroth II, Rybicki EP, Williamson AL.

Immunology. 2006 Dec;119(4):507-14. Epub 2006 Oct 9.

PMID:
17026720
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6.

de Jong A, van Poelgeest MI, van der Hulst JM, Drijfhout JW, Fleuren GJ, Melief CJ, Kenter G, Offringa R, van der Burg SH.

Cancer Res. 2004 Aug 1;64(15):5449-55.

PMID:
15289354
[PubMed - indexed for MEDLINE]
Free Article
11.

Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients.

Achour M, Kahla S, Zeghal D, Kochbati L, Mongi M, Zouari F, Oueslati R.

Viral Immunol. 2009 Feb;22(1):7-16. doi: 10.1089/vim.2008.0009.

PMID:
19210223
[PubMed - indexed for MEDLINE]
12.

Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.

Luxton JC, Rose RC, Coletart T, Wilson P, Shepherd PS.

J Gen Virol. 1997 Apr;78 ( Pt 4):917-23.

PMID:
9129666
[PubMed - indexed for MEDLINE]
Free Article
13.

Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.

de Boer MA, Jordanova ES, van Poelgeest MI, van den Akker BE, van der Burg SH, Kenter GG, Fleuren GJ.

Int J Cancer. 2007 Dec 15;121(12):2711-5.

PMID:
17724722
[PubMed - indexed for MEDLINE]
14.

Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study.

Bierl C, Karem K, Poon AC, Swan D, Tortolero-Luna G, Follen M, Wideroff L, Unger ER, Reeves WC.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S262-8. Epub 2005 Oct 17.

PMID:
16229879
[PubMed - indexed for MEDLINE]
15.

Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.

Rocha-Zavaleta L, Jordan D, Pepper S, Corbitt G, Clarke F, Maitland NJ, Sanders CM, Arrand JR, Stern PL, Stacey SN.

Br J Cancer. 1997;75(8):1144-50.

PMID:
9099962
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia.

Passmore JA, Marais DJ, Sampson C, Allan B, Parker N, Milner M, Denny L, Williamson AL.

J Med Virol. 2007 Sep;79(9):1375-80.

PMID:
17607771
[PubMed - indexed for MEDLINE]
17.

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.

Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB.

J Virol. 2005 Jun;79(11):6741-50.

PMID:
15890912
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Occurrence of the antibody against human papillomavirus type 16 virion protein L2 in patients with cervical cancer and dysplasia.

Kanda T, Teshima H, Katase K, Umezawa S, Watabe H, Takahashi H, Onda T, Yoshiike K.

Intervirology. 1995;38(3-4):187-91.

PMID:
8682615
[PubMed - indexed for MEDLINE]
19.

The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.

Fisher SG, Benitez-Bribiesca L, Nindl I, Stockfleth E, Muller M, Wolf H, Perez-Garcia F, Guzman-Gaona J, Gutierrez-Delgado F, Irvin W, Gissmann L.

Gynecol Oncol. 1996 Apr;61(1):73-8.

PMID:
8626121
[PubMed - indexed for MEDLINE]
20.

Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.

Reuschenbach M, Waterboer T, Wallin KL, Einenkel J, Dillner J, Hamsikova E, Eschenbach D, Zimmer H, Heilig B, Kopitz J, Pawlita M, Doeberitz Mv, Wentzensen N.

Int J Cancer. 2008 Dec 1;123(11):2626-31. doi: 10.1002/ijc.23837.

PMID:
18785210
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk